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Abstract:   The resolution of racemic 3-(methylamino)-1-(2-thienyl)propan-1-ol (3), a 
new key intermediate for duloxetine (1), was studied.  The conditions were optimized 
for an industrial-scale resolution of 3 by using (S)-mandelic acid (4) as a resolving 
agent and 2-butanol containing two equimolar amounts of water as a solvent.  The 
(S)-3･(S)-4･H2O diastereomeric salt was crystallized to give pure (S)-3 with >99.9% 
ee after liberation of the amine.  Absolute configuration of liberated (-)-3 was 
determined as (S)-form by X-ray crystallography. 
 
Introduction 
Up to now, many new and attractive techniques for the production of 
enantiomerically pure compounds have been reported.  Among them, resolution via 
diastereomeric salt formation is still useful to produce enantiomerically pure 
compounds in an industrial-scale, since it is, in general, simple, clean, and easy to 
reproduce laboratory-scale data at an industrial-scale operation.   
Duloxetine (LY-248686), (S)-(+)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl) 
propylamine (1), is expected to be not only a new potent antidepressant but also a 
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norepinephrine (NE) reuptake inhibitor, a 5-HT (serotonin) reuptake inhibitor and a 
new drug for stress urinary incontinence.1  In order to produce a key enantiopure 
intermediate for the synthesis of (S)-1, various strategies have been proposed, such 
as the enantioselective reduction of 3-(dimethylamino)-1-(2-thienyl)propan-1-one2 and 
3-chloro-1-(2-thienyl)propan-1-one3 with Li(ent-Chirald®)2AlH2 and an oxazaborolidine 
catalyst, respectively, the enzymatic resolution of 3-chloro-1-(2-thienyl)propan-1-ol4 
using immobilized CALB (Novozyme 435, Novo-Nordisk A/S), and the resolution of 
3-(dimethylamino)-1-(2-thienyl)propan-1-ol (2)5 via diastereomeric salt formation.  As 
a result, the resolution of (RS)-2 via diastereomeric salt formation with (S)-mandelic 
acid (4) has been selected for an industrial-scale production together with efficient 
supporting techniques such as racemization of the antipode.6  Duloxetine (S)-1 is 
produced by the condensation of the chiral intermediate (S)-2 with 
1-fluoronaphthalene, followed by demethylation with 2,2,2-trichloroethyl chloroformate 
and Zn.2  However, there are some critical problems in this process, such as low yield 
and considerable decomposition to give impurities.  Thus, a direct synthesis starting 
from (S)-3-(methylamino)-1-(2-thienyl)propan-1-ol (3) is expected to be a new route 
for the production of (S)-1.  However, the resolution of (RS)-3 has not been reported 
so far.   
We herein report the resolution of 3-(methylamino)-1-(2-thienyl)propan-1-ol (3) 
with (S)-mandelic acid (4), where water molecules play an important role. 
 
Results and Discussion 
In order to find out a suitable resolving agent for (RS)-3, typical acidic resolving 
agents such as (S)-mandelic acid (4), (R)-2-methoxy-2-phenylacetic acid (5), 
(R)-phenylpropionic acid (6), L-tartaric acid (7), and its dibenzoyl derivative L-8 and 
di-p-toluoyl derivative L-9 were examined by using EtOH as a solvent.  The results 
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are summarized in Table 1.  As can be seen from Table 1, (R)-5 and L-8 gave poor 
results (Table 1, Entries 2 and 5), and (S)-4, (R)-6 and L-7 did not afford any crystals 
(Table 1, Entries 1, 3, and 4).  Although L-9 showed the highest resolution efficiency 
(E),7 the diastereomeric purity (d.p.)8 of the salt was not satisfactory for an 
industrial-scale application (Table 1, Entry 6).   
Then, we checked in detail the conditions for the resolution of (RS)-3 with (S)-4, 
commercially available in a large quantity with low price; especially the resolutions 
were carried out by using various solvents including those applied for the resolution of 
(RS)-2 with (S)-4.  The results are shown in Table 2.  No crystal was obtained from 
solutions of MTBE (tert-butyl methyl ether) and MTBE-EtOH, which are favorable 
solvents in the resolution of (RS)-2 with (S)-4, and from other organic solvents, such 
as 2-butanol, ethyl acetate, ethyl methyl ketone and ethyl ether (Table 2, Entries 1-6).  
In sharp contrast, fine crystals with acceptable diastereomeric purity were obtained 
when water was used as a solvent (Table 2, Entry 7).  The spectral and elemental 
analyses revealed that the salt crystallized from water was monohydrated.  These 
results suggest that water molecules would play an important role in making the 
less-soluble diastereomeric salt crystal stable as a result of the close molecular 
packing of (S)-3, (S)-4 and water molecules.   
In order to improve resolution efficiency, namely to increase the yield of the 
less-soluble diastereomeric salt (S)-3･(S)-4･H2O without any deterioration of the 
diastereomeric purity, we examined the effect of water in ethanol in a range of 2-75% 
(w/w) water contents.  The results are summarized in Table 3.  Table 3 shows that 
the diastereomeric purity increased and then decreased with decreasing water content, 
and finally no crystal was obtained.  On the basis of this result, we considered that 
the presence of water in a solvent is essential to form (S)-3･(S)-4･H2O and that the 
three-component salt would be possible to deposit in a larger quantity from a solvent 
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less polar than ethanol.  Thus, we carried out the resolution by using less polar 
alcohols in the presence of a small amount of water.  The results are summarized in 
Table 4.  As shown in Table 4, the highest resolution efficiency (E) was achieved, 
when 2-butanol containing two molar amounts of water was used as a solvent (Table 4, 
Entry 8).  The diastereomeric salt crystals, obtained in all resolution systems shown 
in Table 4, contained an equimolar amount of water as a component.  These results 
obviously revealed that water played a very important role to form stable 
diastereomeric salt crystals with satisfactory diastereomeric purity.  The 
diastereomeric purity of the crude salt could be easily improved by recrystallizing it 
once from aqueous 2-butanol; the diastereomeric purity of the recrystallized crystals 
was more than 95%.  The final product (S)-3 with more than 99.5% ee was obtained 
upon treatment of the recrystallized salt with aqueous sodium hydroxide, followed by 
extraction with 2-butanol and crystallization from toluene.9   
In order to elucidate the role of water molecules in the formation of the stable 
less-soluble diastereomeric salt crystal, its crystal structure was determined by an 
X-ray crystallographic analysis.  The crystal structure with hydrogen bonds is shown 
in Figures 2 and 3.  As observed by the spectral and elemental analyses, water 
molecules are participated in the crystal formation as connectors between the basic 3 
and the acidic 4 molecules to form a hydrogen-bonded 21 column.  In the crystals of 
the less-soluble diastereomeric salts consisting of mandelic acid and primary 
1-arylalkylamines, such as 1-phenylethylamine, 1-(2-methylphenyl)ethylamine and 
1-(3-methoxyphenyl)ethylamine, hydrogen bonds between the NH(amine) and the 
O(carboxylate) are essential to form a fundamental unit, and other NH(amine)･･･
O(carboxylate) hydrogen bonds generally exist to form a 21-column.10  Moreover, α
-OH(acid)･･･O(carboxylate) hydrogen bonds result in the formation of a 
supramolecularly hydrogen-bonded sheet consisting of the 21 columns.  In sharp 
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contrast, a quite different hydrogen-boding system is observed in this crystal; a 
fundamental unit is constructed from two molecules of 3 and two molecules of 4 
through two water molecules by NH(amine)･･･HOH(water)･･･O(carboxylate) 
hydrogen bonds other than usual NH(amine)･･･O(carboxylate) hydrogen bonds.  
The insertion of water molecules between the NH(amine) and the O(acid) makes the 
distance between them longer, giving an enough space for the N-Me group to avoid 
steric congestion.  In addition, the units are piled up by OH(hydroxyl in 4)･･･
O(carboxylate) hydrogen bonds to form a 21-column.  As a result, the connection of 
the 21 columns is achieved by OH(hydroxyl in 3)･･･O(carboxylate) hydrogen bonds to 
form a hydrogen-bonded supramolecular sheet.  Thus, the less-soluble salt crystal is 
composed of a unique hydrogen-bonding network mediated by water molecules.  
The formation of this unique hydrogen-bonding network would arise from the structural 
feature that 3 is a secondary amine. 
 
Conclusion  
An efficient industrial resolution process of 3-(methylamino)-1-(2-thienyl)propan-1-ol 
(3), a new key intermediate for the synthesis of duloxetine, with (S)-mandelic acid (4) 
has been developed by using 2-butanol with a small amount of water as a solvent.  
From an X-ray crystal structure analysis, the existence of a unique hydrogen-bonding 
network mediated by water molecules was confirmed; water molecules gave a space 
for the bulky N-Me group of 3.  Absolute configuration of liberated (-)-3 was 
determined as (S)-form by X-ray crystallography. 
 
Experimental Section 
General.  Racemic 3 was obtained from Nippon Junryo Chemical (Osaka) and 
used without any purification.  (S)-Mandelic acid (>99.5% ee) was made of 
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Yamakawa Chemical (Tokyo).  Other reagents were purchased from Tokyo Kasei 
Kogyo or Koso Chemical, unless otherwise indicated.   
1H NMR spectra were recorded on a JEOL JNM-ECP400 spectrometer in 
DMSO-d6 or CDCl3 with Me4Si as an internal reference.  IR spectra were measured 
on a JASCO IR-700 spectrometer using KBr pellets.  Optical rotations were 
measured on a JASCO DIP-370 polarimeter with a circular temperature control unit.  
High-performance liquid chromatography was performed by a JASCO Intelligent 
HPLC system equipped with a 875-UV detector.  Melting points were determined with 
a YAMATO MP-21 instrument and uncorrected.  Water content in the salt was 
measured by the Karl Fischer method with a HIRANUMA Aquacounter AQV-5.   
  Determination of Enantiomeric and Diastereomeric Purities.  The enantiomeric 
purity of 3 and the diastereomeric purity of the salt, (S)-3･(S)-4･H2O, were directly 
determined by HPLC using a Shiseido CD-Ph column (ID 4.6 mmX250 mm).  
Analytical conditions for the HPLC were as follows; 0.2 M-NaClO4:MeCN (70:30), 1 
mL/min, 35℃, detected at 235 nm; injection sample 10 μL (15 mg/10 mL), Retention 
times: the (R)-enantiomer 9.8 min, the (S)-enantiomer 12.1 min.  In the analysis of 
the diastereomeric purity of the salt, the peaks of the enantiomers of 3 were 
completely separated from that of (S)-4 (retention time 2.6 min).  
Preparation of the Less-soluble Diastereomeric Salt, (S)-3･(S)-4･H2O.  Pilot 
scale runs usually gave better results than laboratory runs.  A typical pilot run is 
described as follows:  To a 1000 L glass-lined reactor were added (RS)-3 (100 kg, 
584 mol), (S)-4 (89 kg, 584 mol), 2-butanol (190 kg) and water (21 kg, 1168 mol; total 
amount including water in solvent-grade 2-butanol), and the mixture was stirred and 
heated up to about 50℃ to give a clear solution.  The solution was then gradually 
cooled, seeded (20 g) at 34-36℃, kept for one hour at 29-32℃ (corresponding to the 
crystallization temperature), and then cooled again to 20℃.  After aging the 
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suspension at the temperature for one hour, the crystals were collected by a centrifuge 
and washed twice with 2-butanol for each centrifugation (68 L in total; centrifugation 6 
times) to afford the crude salt (83.2 kg, 244 mol, yield 42%, 75% dp, E 63%).  The 
crude salt was recrystallized from a mixture of 2-butanol (165 kg) and water (7 kg; 11 
kg (611 mol) in total including water in the crude salt, 2.5 eq. vs the crude salt).  The 
deposited salt was centrifuged, washed twice with 2-butanol (60 L in total; 
centrifugation 5 times), and dried at 50℃ to give pure (S)-3･(S)-4･H2O (66.1 kg, 194 
mol, yield 79 %, 95% dp).   
(S)-3･(S)-4･H2O: [α]D20 +26.4°(c 1.00, EtOH); Mp 70–71℃; IR (KBr) cm-1: 3470, 
3208, 1618, 1586, 1491, 1051, 701; 1H NMR (DMSO-d6, 400 MHz): δ 7.37-7.40 (m, 
3H), 7.22-7.25 (m. 2H), 7.17 (d, J=5.2 Hz, 1H), 6.96 (dd, J=3.2, 5.2 Hz, 1H), 6.90 (d, 
J=3.2 Hz, 1H), 4.89 (dd, J=4.8, 8.0 Hz, 1H), 4.60 (s, 1H), 2.86-2.91 (m, 2H), 2.44 (s, 
3H), 1.92-1.99 (m, 2H); Water content (KF): Calcd for a hydrate 5.25 %, found 5.27 %; 
Anal. Calcd for C16H23NO5S: C, 56.29; H, 6.79; N, 4.10, S, 9.39.  Found C, 56.25; H, 
6.64; N, 4.10; S, 9.36. 
Preparation of (S)-3.  The pure salt (S)-3･(S)-4･H2O (66.1 kg) was treated with 
1.2 M sodium hydroxide (194 L), and the liberated (S)-3 was extracted with 2-butanol 
(124 L X 3).  The combined 2-butanol layers were concentrated under reduced 
pressure.  To the condensate was added toluene, and remaining 2-butanol was 
removed upon evaporating repeatedly to change the solvent to toluene completely.  
To the final condensate was added toluene (322 L), and precipitated sodium 
(S)-mandelate was filtered off.  The filtrate was concentrated to 95 L under reduced 
pressure.  The suspension was heated at 50℃ to dissolve the precipitates, then 
gradually cooled, seeded (20 g) at 45℃, kept for one hour at around crystallization 
temperature (42℃), and then cooled again to 20℃.  After aging the suspension at the 
temperature for one hour, the crystals were collected by a centrifuge and washed 
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twice with toluene for each centrifugation (24 L in total; centrifugation 2 times) to afford 
the white crystals of (S)-3 (27.2 kg, 159 mol, Yield 82%, >99.9% ee, Total yield 27%). 
(S)-3: [α]D20 –16.5°(c 1.01, EtOH); Mp 70.5–73.0℃; IR (KBr) cm-1: 3384, 3284, 1489, 
1303, 1178, 1110, 1085, 709; 1H NMR (CDCl3, 400 MHz): δ 7.20 (d, J=5.2 Hz, 1H), 
6.96 (dd, J=3.2, 5.2 Hz, 1H), 6.92 (d, J=3.2 Hz, 1H), 5.17 (dd, J=3.2, 8.0 Hz, 1H), 2.94 
(ddd, J=3.6, 5.6, 8.0 Hz, 1H), 2.84 (ddd, J=3.2, 9.2, 12.0 Hz, 1H), 2.42 (s, 3H), 
1.85-2.00 (m, 2H); Anal. Calcd for C8H13NOS: C, 56.11; H, 7.65; N, 8.18; S, 18.72.  
Found C, 56.22; H, 7.56; N, 8.17; S, 18.79. 
X-Ray Crystal Structure Analysis.  A colorless plate single crystal of (S)-3･(S)-4･
H2O salt (0.30X0.70X0.70 mm) was grown from the recrystallization conditions 
indicated above using the recrystallized salt crystals (>99.9% dp; (S)-mandelic acid 
>99.9% ee).  The X-ray intensities were measured up to 2θmax=52.7°with graphite 
monochromated MoKα radiation (λ=0.71073Å) (MAC Science) at 296K.   
Data collection and refinement parameters for the salt are as follows:  
(S)-3･(S)-4･H2O; C16H23NO5S; Formula Weight 341.42; Monoclinic; Space group: 
P21(#4), a=8.8150(4)Å, b=5.8730(2)Å, c=17.5500(9)Å, β=92.573(2)°, 
V=876.77(6)Å3, Z=2, Dcalc=1.293 g/cm3, μ(MoKα)=2.08 cm
-1, R=0.054, Rw=0.082.  
Number of reflections measured=Total 1961; Unique: 1959.  Crystallographic data 
(excluding structure factors) for the structure in this paper have been deposited with 
the Cambridge Crystallographic Data Centre as a supplementary publication number 
CCDC 203963.   
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Table 1.  Resolution of (RS)-3 with various resolving agents in EtOH 
 
Entry 
Resolving 
agent 
Solvent/(RS)-3 
ratio  
(w/w) 
 
Yield 
% 
Diastereomeric 
purity 
%dp 
Resolution 
efficiency (E) 
% 
Absolute 
Configuration 
1 (S)-4 3  Not crystallized  0  
2 (R)-5 2.3 4 63 5 S 
3 (R)-6 5 Not crystallized  0  
4 L-7 5 Not crystallized  0  
5 L-8 5 74 9 13 R 
6 L-9 5 47 53 50 S 
4: Mandelic acid. 5: 2-Methoxy-2-phenylacetic acid. 6: Phenylpropionic acid. 7: Tartaric acid.  
8: Dibenzoyltartaric acid. 9: Ditoluoyltartaric acid.  
* Molar ratio of resolving agent: 1.0 eq. vs racemate.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 12 
Table 2.  Resolution of (RS)-3 with (S)-mandelic acid (4) in various solvents*1 
 
Entry 
 
Solvent*2 
 
 
Yield 
% 
Diastereomeric 
purity 
%dp 
Resolution 
efficiency (E) 
% 
Absolute 
configuration 
1 MTBE Not crystallized  0  
2 MTBE-EtOH*3 Not crystallized  0  
3 2-BuOH Not crystallized  0  
4 AcOEt Not crystallized  0  
5 MEK Not crystallized  0  
6 Ethyl ether Not crystallized  0  
7 Water 20 75 30 S 
*1: Resolving agent/(RS)-3=1.0 (molar ratio) 
*2: Solvent/(RS)-3 = 1.9 (w/w) 
*3: MTBE/EtOH=2:1 (w/w) 
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Table 3.  Resolution of (RS)-3 with (S)-mandelic acid (4) in water/EtOH 
 
Entry 
Water/EtOH 
Ratio 
(w/w)*1 
 
Yield 
% 
Diastereomeric 
purity 
%dp 
Resolution 
efficiency (E) 
% 
1 100/0 30 68 41 
2 75/25 15 72 22 
3 50/50 2 86 3 
4 25/75 8 85 14 
5 5/95 11 70 15 
6 2/98 Not crystallized  0 
7 0/100 Not crystallized  0 
*1: Solvent/(RS)-3=1.9 (w/w); 5%(w/w) of water means equimolar amount of (RS)-3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 14 
Table 4.  Optical resolution of (RS)-3 with (S)-4 in alcohols containing water*1 
 
Entry 
 
Solvent*2 
Water/(RS)-3 
ratio  
[molar ratio] 
 
Yield 
% 
Diastereomeric 
purity 
%dp 
Resolution 
efficiency 
(E) % 
1 n-PrOH 1.0 20 71 28 
2 2-PrOH 1.0 32 74 47 
3 2.0 47 55 52 
4 3.0 40 71 57 
5 n-BuOH 1.0 39 67 52 
6 2.0 36 75 54 
7 2-BuOH 1.0 40 63 50 
8 2.0 45 70 63 
9 3.0 39 73 57 
10  4.0 32 76 49 
*1: (S)-4/(RS)-3=1.0 (molar ratio). 
*2: Solvent/(RS)-3=1.9 (w/w) 
 
